Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Importance of Screening for HCC in HBV: Patient and Physician Sharing Session #7

Source: Addressing Misunderstandings in Applying HBV Treatment Guidelines
In this episode in our series of sharing sessions between a physician and patient, Ming-Lung Yu, MD, PhD, and his patient, who is living with chronic hepatitis B, discuss the importance of screening for HCC even when HBeAg negative without overt ALT elevation.
Ming-Lung Yu, MD, PhD
Released: April 12, 2022

In episode 7 of a series of sharing sessions between a physician and patient, Ming-Lung Yu, MD, PhD, and his patient, who is living with chronic hepatitis B, discuss:

  • Role of family history in risk of hepatocellular carcinoma (HCC)
  • Surveillance for HCC
  • Steps to take when diagnosed with HCC
  • How to live a healthy life after HCC diagnosis and treatment

Information on this Educational Activity

Faculty

Ming-Lung Yu, MD, PhD

Chair Professor
Hepatobiliary Division
Department of Internal Medicine and Hepatitis Center
Kaohsiung Medical University
Visiting Staff
Hepatobiliary Division
Department of Internal Medicine
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan

Ming-Lung Yu, MD, PhD, has disclosed that he has received funds for research support from Abbott, Bristol-Myers Squibb, Gilead Sciences, and Merck; consulting fee sform AbbVie, Abbott, Ascletis, Bristol-Myers Squibb, Gilead Sciences, Merck, and Roche; and fees for non-CME/CE services from AbbVie, Abbott, Bristol-Myers Squibb, Gilead Sciences, Ipsen, and Merck.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Theo Tiến sĩ Nancy Reau, chúng ta có thể biết các hướng dẫn thực hiện sàng lọc virus viêm gan D thông qua các biện pháp chăm sóc lâm sàng (CCO)

Nancy Reau, MD Released: January 26, 2023

Matuto mula kay Dr Nancy Reau kung bakit maaaring gusto naming hamunin ang mga kasalukuyang alituntunin sa pagsusuri ng HDV, mula sa Clinical Care Options (Mga Opsyon sa Klinikal na Pangangalaga) (CCO)

Nancy Reau, MD Released: January 26, 2023

从 Nancy Reau 博士那里了解我们为什么要挑战当前的 HDV 筛查指南，来自 Clinical Care Options (CCO)

Nancy Reau, MD Released: January 25, 2023

Dr Graham Foster on optimizing management of HBV in older adults, from Clinical Care Options (CCO)

Graham R. Foster, FRCP, PhD Released: January 17, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings